SCHEMBL6943584

SCHEMBL6943584

CC(C)C[C@@H](C(=O)NN(c1ccccc1)S(C)(=O)=O)[C@H](CNC(=O)c1ccccc1)C(=O)NOC1CCCCO1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HPGD P15428 2/20 0.34
CYP2C9 P11712 1/20 0.34
RECQL P46063 1/20 0.34
P2RX3 P56373 1/20 0.34
POLB P06746 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ITGAV P06756 1/20 0.33
CTSD P07339 2/20 0.33
BACE1 P56817 2/20 0.33
BACE2 Q9Y5Z0 2/20 0.33
ADAM17 P78536 1/20 0.33
MAPK1 P28482 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6938021 0.89 ALDH1A1 (0.35) SMN1; SMN2POLBADAM17ALDH1A1
SCHEMBL6946107 0.86 ADAM17 (0.38) P2RX3POLBCTSDADAM17
SCHEMBL6940045 0.84 KMT2A (0.34) SMN1; SMN2KMT2AHPGDPOLBADAM17
SCHEMBL6947352 0.84 ADAM17 (0.51) MEN1KMT2AP2RX3POLBADAM17
SCHEMBL6939991 0.83 MMP1 (0.42) MEN1KMT2ACYP2C9POLBADAM17
SCHEMBL6940054 0.83 CTSK (0.38) MEN1KMT2APOLBCTSDBACE1
SCHEMBL6942385 0.83 ADAM17 (0.45) SMN1; SMN2MEN1KMT2AP2RX3POLB
SCHEMBL8099196 0.81 ADAM17 (0.33) P2RX3POLBADAM17
SCHEMBL6945960 0.80 ADAM17 (0.51) P2RX3ADAM17
SCHEMBL6946852 0.80 ADAM17 (0.40) P2RX3POLBADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993442-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-04-23 EP disclosed
US-6235787-B1 ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. 2001-05-22 US disclosed